Tokyo Joe's Cafe / Societe Anonyme/No Pennies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jane4IceCream who wrote (6850)	10/21/1998 5:57:00 PM
From: blackmerlin	Read Replies (2) of 119973

Jane & TokyoMex: My DD tells me ENMD looks good again: Timing seems to be everything with this stock as you know from early October versus now. However, despite inaccurate information posted by Gigabucks on Yahoo, the real DD is that things are still looking good for EntreMed (in lieu of the Noble Prize for Folkman). Of course, if one calls Bristol Myers Squibb, they will tell you the official timeline for angiostatin Phase I in humans is starting late 1999 (this allows for some wiggle room). However, the scientists that I talked to today while in Boston mentioned that the final cell line for the manufacturing of angiostatin has been chosen (based on collaborative BMS and ENMD studies), BMS has allocated the money needed to make the material needed for Phase I, and BMS has fermenters ready to go. So the unofficial unpublished time to human clinical trials looks more optimistic by a few months than the PR timelines as things stand right now. So I am still recommending the stock, and to the upside a few points in the short term. Regards, Blackmerlin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next